Trump announces trade deal with EU following months of negotiations
Investing.com -- Shares of Jenoptik slid by 3.2% as the company reported weaker than expected first-quarter results. Jenoptik continues to forecast sales to remain at the previous year’s level, with an expected EBITDA margin between 18-21%.
Despite a recent uptick in demand, the company acknowledged heightened risks due to ongoing tariff discussions that could impact its operations.
The order intake for the first quarter was reported at €204.6m, marking a significant decline of 15.5% YoY. The SAM business segment saw a substantial 42% drop in order intake, attributed to lower demand and a one-time product adjustment. However, all other divisions experienced an increase in orders.
The book-to-bill ratio, an indicator of future revenue, fell to 0.84 from 0.94 year on year. The order backlog decreased to €622m, a 7% reduction from €67m at the end of the fourth quarter in 2024.
Despite the disappointing order intake, Jenoptik did have some positive news with its free cash flow (FCF) before interest and taxes, which saw a significant improvement in the first quarter of 2025, reaching €28.9m compared to €19.5m in the prior year. This improvement was driven by a strong operating cash flow performance.
Jefferies, a financial services company, commented on Jenoptik’s performance, stating that the company published "weak Q1 figures."
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.